Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Psychemedics Corp

+ Add to Watchlist

PMD:US

16.4100 USD 0.5800 3.66%

As of 20:10:00 ET on 02/27/2015.

Snapshot for Psychemedics Corp (PMD)

Open: 15.9400 Day's Range: 15.9300 - 16.4200 Volume: 7,585
Previous Close: 15.8300 52wk Range: 12.4200 - 18.4000 1-Yr Rtn: -4.14%

Stock Chart for PMD

No chart data available.
  • PMD:US 16.4100
  • 1D
  • 1M
  • 1Y
15.8300
Interactive PMD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PMD

Current P/E Ratio (ttm) 27.3500
Estimated P/E(12/2015) 17.6452
Relative P/E vs. SPX 1.5671
Earnings Per Share (USD) (ttm) 0.6000
Est. EPS (USD) (12/2015) 0.9300
Est. PEG Ratio 0.8823
Market Cap (M USD) 88.20
Shares Outstanding (M) 5.38
30 Day Average Volume 6,845
Price/Book (mrq) 6.8714
Price/Sale (ttm) 3.0091
Dividend Indicated Gross Yield 3.66%
Cash Dividend (USD) 0.1500
Dividend Ex-Date 02/19/2015
5 Year Dividend Growth 0.68%
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PMD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PMD

Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. The Company's testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry. Psychemedics screens for the presence of certain drugs of abuse in hair.

Raymond C Kubacki Jr "Ray"Chairman/President/CEONeil L LernerVP:Finance/Treasurer
Sarah AshbyVP/General CounselJames V Dyke "Jim"VP:Sales & Marketing
More Company Profile & Key Executives for PMD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil